An individual approach

Ricki Lewis

Nature, 2005, vol. 436, issue 7051, 746-747

Abstract: Reduced side effects and more effective therapies are some of the benefits promised by pharmacogenomics. But to reach these goals industry will have to marshall a broad range of skills, as Ricki Lewis explains.

Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/nj7051-746a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:436:y:2005:i:7051:d:10.1038_nj7051-746a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nj7051-746a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().